SUNDAY, June 2, 2019 -- Cutting-edge prostate cancer drugs that help extend life in the toughest cases might also be useful in fighting less aggressive tumors, two new clinical trials suggest.
Two drugs that interfere with cancer's ability to use testosterone for fuel, apalutamide (Erleada) and enzalutamide (Xtandi), are already approved for use against more advanced prostate tumors that don't respond to regular therapy.
MONDAY, May 20, 2019 -- For all of those men who view a mustache as a largely ornamental addition to their masculine appearance, a new study reveals it can also guard against lip cancer.
"Mustaches seem to protect the lip the same way that hair protects the scalp," explained study author Dr. Daniel Aires. He is director of dermatology with the University of Kansas Health System. "While this makes intuitive sense, it had not been tested before."
SATURDAY, May 4, 2019 -- Buyer beware: When it comes to testosterone supplements, men should know a new study finds there is precious little evidence to support claims they will boost testosterone levels, sex drive, strength and overall energy.
To come to this conclusion, the researchers first broke down 50 testosterone supplements into their component parts.
TUESDAY, April 30, 2019 -- Treating men with low-risk prostate cancer with just one high dose of radiation may be safe and effective, British researchers report.
Therapy for prostate cancer typically involves low-dose radiation given over several days or weeks. Conversely, high-dose radiation is given once through a set of tiny tubes inserted directly into the tumor.